Merrill Lynch Br. SmallerCo Tst PLC
13 October 2006
MERRILL LYNCH BRITISH SMALLER COMPANIES TRUST plc
All information is at 30 September 2006 and unaudited.
Performance at month end is calculated on a capital only basis
One Three One Three Five
Month Months Year Years Years
Net asset value 3.5% 4.1% 19.9% 85.2% 103.8%
Share price 5.8% 6.6% 21.3% 98.5% 124.1%
FTSE SmallCap Index (ex IC's) 3.0% 4.7% 12.4% 45.0% 61.0%
Sources: BlackRock Merrill Lynch Investment Managers and Datastream.
At month end
Net asset value: 371.69p
Share price: 320.50p
Discount to NAV: 13.8%
Net yield: 1.4%
Total assets: £202.7m
Gearing: 7.9%
Ordinary shares in issue: 50,563,523
Ten Largest Sector
Weightings % of Total Assets
Support Services 17.6
Software & Computer Services 9.1
Real Estate 8.6
Industrial Engineering 8.0
Electronic & Electrical Equipment 6.4
Oil & Gas Producers 6.1
Media 5.7
General Financial 5.7
Mining 4.4
Construction & Materials 3.7
----
Total 75.3
----
Ten Largest Equity Investments (in alphabetical order)
Company
Aveva Group
Brewin Dolphin
BSS Group
Chaucer Holdings
Dechra Pharmaceuticals
Kier Group
Mouchel Parkman
Rathbone Brothers
Spirax-Sarco Engineering
WSP Group
Commenting on the markets, Mike Prentis, representing the Investment Manager
noted:
September was a better month for the Company. The NAV rose by 3.5% on a capital
only basis to 371.69 pence. By comparison the benchmark index rose by 3.0%.
The main positive contributors to the improved performance in September were our
holdings in Aveva, SHL, Hardman Resources, Plant Health Care, Kier Group, Redrow
and Xaar. Aveva announced a very positive trading update commenting on buoyant
markets (power generation, oil and gas, and ship building are all important) for
their software and a number of contracts coming through faster than expected.
Kier also announced strong results leading to 10% upgrades. Plant Health Care is
earlier stage but commented that business was strong and that global trials for
their Myconate product, which improves agricultural yields markedly, had gone
well, as had trials of Pre-Tect which extends the shelf life of perishable
products. Discussions are being held with potential partners. SHL and Hardman
Resources both attracted cash bids albeit at premia that are not compelling
compared to peak share prices over the last six months. Redrow shares performed
well on confident final results, and rumours of a bid. Xaar shares began to
recover following a positive presentation by management on release of their
interim results.
The largest negative impact on relative performance in September came from
Avocet Mining which released a profit warning mainly due to higher production
costs. We had met the company's management in August, so the warning was
unexpected and the share price fall substantial. Our view is that following this
fall the shares are even better value long term, although in the short term
management credibility has suffered. We view the stock as a firm hold and would
be a modest, opportunistic buyer.
Major new holdings in the month included Dignity, Care UK, Bond International
Software and Invista Real Estate. Dignity is the UK's leading funeral directors,
a success since IPO but still with a modest market share. Care UK provides care
to the elderly and disabled. Both of these companies are UK focused and have
good predictability of revenues. Bond which provides software to recruitment
companies globally, is showing strong growth having launched updates, and has a
good level of recurring revenue. Invista floated during the month and is the
real estate management arm of HBOS.
We sold our holding in Playtech following increased concerns about the US
authorities intentions to curb online gaming - this proved to be reasonable
timing as the US Senate later passed legislation designed to prevent online
payments for gaming. We took profits in holdings in Derwent Valley, Quintain and
Big Yellow, all high quality real estate companies following good share price
performances.
Latest information is available by typing www.blackrock.co.uk/its on the
internet, 'BLRKINDEX' on Reuters, 'BLRK' on Bloomberg or '8800' on Topic 3 (ICV
terminal).
13 October 2006
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.